Neurogenic bladder in spinal cord injury patients

Research and Reports in Urology

Volumn 7, Issue , 2015, Pages 85-99

  Taweel, Waleed Al ^a   Seyam, Raouf ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Intermittent catheterization; Intestine; Neurogenic bladder; Spinal cord injury; Urodynamics

Indexed keywords

BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; COTRIMOXAZOLE;

AUTONOMIC DYSREFLEXIA; AUTONOMIC NERVE; BLADDER AND BOWEL MANAGEMENT; BLADDER CANCER; BLADDER EMPTYING; BLADDER FUNCTION; BLADDER SPHINCTER PROSTHESIS; BLADDER STONE; CATHETERIZATION; CONSERVATIVE TREATMENT; CYSTOSCOPY; ELECTROSTIMULATION; EPIDIDYMITIS; HUMAN; INCONTINENCE; INDWELLING CATHETER; KIDNEY FAILURE; META ANALYSIS (TOPIC); MUSCLE GRAFT; NEPHROLITHIASIS; NERVE TRANSPLANTATION; NEUROGENIC BLADDER; NEUROMODULATION; PATIENT EDUCATION; PROSTATITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TRANSOBTURATOR TAPE; URETHRAL STENT; URETHRITIS; URINARY DIVERSION; URINARY TRACT INFECTION; URODYNAMICS;

EID: 84941205313     PISSN: None     EISSN: 22532447     Source Type: Journal    
DOI: 10.2147/RRU.S29644     Document Type: Review

References (143)

1. Noreau L, Noonan VK, Cobb J, Leblond J, Dumont FS. Spinal cord injury community survey: a national, comprehensive study to portray the lives of Canadians with spinal cord injury. Top Spinal Cord Inj Rehabil. 2014;20(4):249-264.
2. Shingleton WB, Bodner DR. The development of urologic complications in relationship to bladder pressure in spinal cord injured patients. J Am Paraplegia Soc. 1993;16(1):14-17.
3. Tang DH, Colayco D, Piercy J, Patel V, Globe D, Chancellor MB. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol. 2014;14:74.
4. Manack A, Motsko SP, Haag-Molkenteller C, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn. 2011;30(3):395-401.
5. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453-466.
6. Rossier AB, Fam BA, Dibenedetto M, Sarkarati M. Urodynamics in spinal shock patients. J Urol. 1979;122(6):783-787.
7. Hiersemenzel LP, Curt A, Dietz V. From spinal shock to spasticity: neuronal adaptations to a spinal cord injury. Neurology. 2000;54(8): 1574-1582.
8. McGuire EJ, Savastano JA. Long-term follow-up of spinal cord injury patients managed by intermittent catheterization. J Urol. 1983;129(4): 775-776.
9. Rudy DC, Awad SA, Downie JW. External sphincter dyssynergia: an abnormal continence reflex. J Urol. 1988;140(1):105-110.
10. Abdel-Azim M, Sullivan M, Yalla SV. Disorders of bladder function in spinal cord disease. Neurol Clin. 1991;9(3):727-740.
11. Clarke SJ, Thomas DG. Characteristics of the urethral pressure profile in flaccid male paraplegics. Br J Urol. 1981;53(2):157-161.
12. McGuire EJ, Morrissey SG. The development of neurogenic vesical dysfunction after experimental spinal cord injury or sacral rhizotomy in non-human primates. J Urol. 1982;128(6):1390-1393.
13. Cardenas DD, Mayo ME. Bacteriuria with fever after spinal cord injury. Arch Phys Med Rehabil. 1987;68(5 Pt 1):291-293.
14. De Ridder DJ, Everaert K, Fernández LG, et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial. Eur Urol. 2005;48(6): 991-995.
15. Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med. 1993;95(2):141-152.
16. Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterization following spinal cord injury. J Urol. 1984;132(5):943-946.
17. Morton SC, Shekelle PG, Adams JL, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil. 2002;83(1):129-138.
18. Salomon J, Denys P, Merle C, et al. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up-an observational prospective study. J Antimicrob Chemother. 2006;57(4): 784-788.
19. Lee BB, Haran MJ, Hunt LM, et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord. 2007;45(8):542-550.
20. Hull R, Rudy D, Donovan W, et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol. 2000;163(3):872-877.
21. Buczyński AZ. Principles for urological management of SCI patients. Ortop Traumatol Rehabil. 2000;2(1):57-60.
22. Park YI, Linsenmeyer TA. A method to minimize indwelling catheter calcification and bladder stones in individuals with spinal cord injury. J Spinal Cord Med. 2001;24(2):105-108.
23. Chen Y, DeVivo MJ, Stover SL, Lloyd LK. Recurrent kidney stone: a 25-year follow-up study in persons with spinal cord injury. Urology. 2002;60(2):228-232.
24. Hackler RH, Dalton JJ Jr, Bunts RC. Changing concepts in the preservation of renal function in the paraplegic. J Urol. 1965;94:107-111.
25. Hess MJ, Zhan EH, Foo DK, Yalla SV. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med. 2003;26(4):335-338.
26. Elliott S, Krassioukov A. Malignant autonomic dysreflexia in spinal cord injured men. Spinal Cord. 2006;44(6):386-392.
27. Altaweel W, Corcos J. Pathophysiology of autonomic dysreflexia. In: Corcos J, Schick E, editors. Textbook of the Neurogenic Bladder. London, UK: Martin Dunitz, Taylor and Francis Group; 2004.
28. Hou S, Rabchevsky AG. Autonomic consequences of spinal cord injury. Compr Physiol. 2014;4(4):1419-1453.
29. Panicker JN, de Sèze M, Fowler CJ. Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin Rehabil. 2010;24(7):579-589.
30. Welk B, Morrow S, Madarasz W, Baverstock R, Macnab J, Sequeira K. The validity and reliability of the neurogenic bladder symptom score. J Urol. 2014;192(2):452-457.
31. Klausner AP, Steers WD. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am. 2011;95(1):111-120.
32. Mahfouz W, Corcos J. Management of detrusor external sphincter dyssynergia in neurogenic bladder. Eur J Phys Rehabil Med. 2011;47(4): 639-650.
33. Stöhrer M, Blok B, Castro-Diaz D, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56(1):81-88.
34. Watanabe T, Rivas DA, Chancellor MB. Urodynamics of spinal cord injury. Urol Clin North Am. 1996;23(3):459-473.
35. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126(2): 205-209.
36. Danforth TL, Ginsberg DA. Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics? Urol Clin North Am. 2014;41(3):445-452.
37. Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn. 2007;26(2):228-233.
38. Marks BK, Goldman HB. Videourodynamics: indications and technique. Urol Clin North Am. 2014;41(3):383-391.
39. Liu CW, Attar KH, Gall A, Shah J, Craggs M. The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK. Spinal Cord. 2010;48(4):319-324.
40. Engkasan JP, Ng CJ, Low WY. Factors influencing bladder management in male patients with spinal cord injury: a qualitative study. Spinal Cord. 2014;52(2):157-162.
41. Oh SJ, Ku JH, Jeon HG, Shin HI, Paik NJ, Yoo T. Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury. Urology. 2005;65(2):306-310.
42. Thietje R, Giese R, Pouw M, et al. How does knowledge about spinal cord injury-related complications develop in subjects with spinal cord injury? A descriptive analysis in 214 patients. Spinal Cord. 2011;49(1): 43-48.
43. Vaidyanathan S, Singh G, Soni BM, et al. Do spinal cord injury patients always get the best treatment for neuropathic bladder after discharge from regional spinal injuries centres? Spinal Cord. 2004;42(8): 438-442.
44. Chang SM, Hou CL, Dong DQ, Zhang H. Urologic status of 74 spinal cord injury patients from the 1976 Tangshan earthquake, and managed for over 20 years using the Credé maneuver. Spinal Cord. 2000;38(9): 552-554.
45. Jackson AB, DeVivo M. Urological long-term follow-up in women with spinal cord injuries. Arch Phys Med Rehabil. 1992;73(11):1029-1035.
46. Hansen RB, Biering-Sørensen F, Kristensen JK. Bladder emptying over a period of 10-45 years after a traumatic spinal cord injury. Spinal Cord. 2004;42(11):631-637.
47. Rabadi MH, Aston C. Complications and urologic risks of neurogenic bladder in veterans with traumatic spinal cord injury. Spinal Cord. November 18, 2014. [Epub ahead of print.]
48. Wyndaele JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord. 2002;40(10):536-541.
49. Prieto-Fingerhut T, Banovac K, Lynne CM. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabil Nurs. 1997;22(6):299-302.
50. Spinu A, Onose G, Daia C, et al. Intermittent catheterization in the management of post spinal cord injury (SCI) neurogenic bladder using new hydrophilic, with lubrication in close circuit devices-our own preliminary results. J Med Life. 2012;5(1):21-28.
51. Giannantoni A, Di Stasi SM, Scivoletto G, Virgili G, Dolci S, Porena M. Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: a prospective randomized crossover study. J Urol. 2001;166(1):130-133.
52. Ku JH, Oh SJ, Jeon HG, et al. Sexual activity in Korean male patients on clean intermittent catheterization with neurogenic bladder due to spinal cord injury. Int J Urol. 2006;13(1):42-46.
53. Oh SJ, Shin HI, Paik NJ, Yoo T, Ku JH. Depressive symptoms of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury. Spinal Cord. 2006;44(12):757-762.
54. Esclarín De Ruz A, García Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000;164(4):1285-1289.
55. West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology. 1999;53(2):292-297.
56. Chao R, Clowers D, Mayo ME. Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury. Urology. 1993;42(3): 259-262.
57. Yang CC, Clowers DE. Screening cystoscopy in chronically catheterized spinal cord injury patients. Spinal Cord. 1999;37(3):204-207.
58. Ahluwalia RS, Johal N, Kouriefs C, Kooiman G, Montgomery BS, Plail RO. The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl. 2006;88(2):210-213.
59. Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000;163(3): 768-772.
60. Mitsui T, Minami K, Furuno T, Morita H, Koyanagi T. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol. 2000;38(4):434-438.
61. MacDiarmid SA, Arnold EP, Palmer NB, Anthony A. Management of spinal cord injured patients by indwelling suprapubic catheterization. J Urol. 1995;154(2 Pt 1):492-494.
62. Weld KJ, Graney MJ, Dmochowski RR. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol. 2000;163(4):1228-1233.
63. Bennett CJ, Young MN, Adkins RH, Diaz F. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol. 1995;153(5):1458-1460.
64. del Popolo G, Mencarini M, Nelli F, Lazzeri M. Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: a literature overview. Spinal Cord. 2012;50(1):8-13.
65. Madersbacher H, Mürtz G, Stöhrer M. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord. 2013;51(6):432-441.
66. Kennelly MJ, Lemack GE, Foote JE, Trop CS. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study. Urology. 2009;74(4):741-745.
67. George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. Scientific World Journal. 2007;7:1683-1690.
68. Nardulli R, Losavio E, Ranieri M, et al. Combined antimuscarinics for treatment of neurogenic overactive bladder. Int J Immunopathol Pharmacol. 2012;25(1 Suppl):35S-41S.
69. Bennett N, O'Leary M, Patel AS, Xavier M, Erickson JR, Chancellor MB. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol. 2004;171(2 Pt 1):749-751.
70. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164(3 Pt 1):692-697.
71. Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60(4):742-750.
72. Reitz A, Stöhrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol. 2004;45(4):510-515.
73. Schurch B, de Sèze M, Denys P, et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005;174(1):196-200.
74. Grosse J, Kramer G, Stöhrer M. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol. 2005;47(5):653-659.
75. Kuo HC, Liu SH. Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries. Neurourol Urodyn. 2011;30(8):1541-1545.
76. Del Popolo G, Filocamo MT, Li Marzi V, et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol. 2008;53(5):1013-1019.
77. Giannantoni A, Mearini E, Del Zingaro M, Porena M. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol. 2009;55(3):705-711.
78. US Food and Drug Administration. FDA approves Botox to treat specific form of urinary incontinence. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm269509.htm. Accessed March 8, 2015.
79. Madersbacher S, Schmidt J, Eberle JM, et al. Long-term outcome of ileal conduit diversion. J Urol. 2003;169(3):985-990.
80. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012;109(9):1280-1293.
81. Linder A, Leach GE, Raz S. Augmentation cystoplasty in the treatment of neurogenic bladder dysfunction. J Urol. 1983;129(3):491-493.
82. Gurung PM, Attar KH, Abdul-Rahman A, Morris T, Hamid R, Shah PJ. Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10 years of follow-up. BJU Int. 2012;109(8):1236-1242.
83. Chen JL, Kuo HC. Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury. J Formos Med Assoc. 2009;108(6):475-480.
84. Sidi AA, Becher EF, Reddy PK, Dykstra DD. Augmentation enterocystoplasty for the management of voiding dysfunction in spinal cord injury patients. J Urol. 1990;143(1):83-85.
85. Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P. Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord. 2000;38(8):490-494.
86. Gobeaux N, Yates DR, Denys P, Even-Schneider A, Richard F, Chartier-Kastler E. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results. Neurourol Urodyn. 2012;31(5):672-676.
87. Gill IS, Rackley RR, Meraney AM, Marcello PW, Sung GT. Laparoscopic enterocystoplasty. Urology. 2000;55(2):178-181.
88. Rackley RR, Abdelmalak JB. Laparoscopic augmentation cystoplasty. Surgical technique. Urol Clin North Am. 2001;28(3):663-670.
89. Kang IS, Lee JW, Seo IY. Robot-assisted laparoscopic augmentation ileocystoplasty: a case report. Int Neurourol J. 2010;14(1):61-64.
90. McDougal WS. Metabolic complications of urinary intestinal diversion. J Urol. 1992;147(5):1199-1208.
91. Wagstaff KE, Woodhouse CR, Duffy PG, Ransley PG. Delayed linear growth in children with enterocystoplasties. Br J Urol. 1992;69(3): 314-317.
92. Mundy AR, Nurse DE. Calcium balance, growth and skeletal mineralisation in patients with cystoplasties. Br J Urol. 1992;69(3):257-259.
93. Blyth B, Ewalt DH, Duckett JW, Snyder HM 3rd. Lithogenic properties of enterocystoplasty. J Urol. 1992;148(2 Pt 2):575-577.
94. Mathoera RB, Kok DJ, Nijman RJ. Bladder calculi in augmentation cystoplasty in children. Urology. 2000;56(3):482-487.
95. Herschorn S, Hewitt RJ. Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology. 1998;52(4):672-678.
96. Rosenbaum DH, Cain MP, Kaefer M, et al. Ileal enterocystoplasty and B12 deficiency in pediatric patients. J Urol. 2008;179(4):1544-1547.
97. Hamid R, Greenwell TJ, Nethercliffe JM, Freeman A, Venn SN, Woodhouse CR. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary? BJU Int. 2009;104(3):392-395.
98. Sung MT, Zhang S, Lopez-Beltran A, et al. Urothelial carcinoma following augmentation cystoplasty: an aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations. Histopathology. 2009;55(2):161-173.
99. Higuchi TT, Granberg CF, Fox JA, Husmann DA. Augmentation cystoplasty and risk of neoplasia: fact, fiction and controversy. J Urol. 2010;184(6):2492-2496.
100. Adams MC, Mitchell ME, Rink RC. Gastrocystoplasty: an alternative solution to the problem of urological reconstruction in the severely compromised patient. J Urol. 1988;140(5 Pt 2):1152-1156.
101. Nguyen DH, Bain MA, Salmonson KL, Ganesan GS, Burns MW, Mitchell ME. The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach. J Urol. 1993;150(2 Pt 2):707-709.
102. Kinahan TJ, Khoury AE, McLorie GA, Churchill BM. Omeprazole in post-gastrocystoplasty metabolic alkalosis and aciduria. J Urol. 1992;147(2):435-437.
103. Al-Azzawi Y, Galloway N, Keilin S. Management of bleeding-associated severe gastritis of the gastric mucosa in a patient with a gastrocystoplasty. J Clin Gastroenterol. 2014;48(4):360-361.
104. Husmann DA. Malignancy after gastrointestinal augmentation in childhood. Ther Adv Urol. 2009;1(1):5-11.
105. Castellan M, Gosalbez R, Bar-Yosef Y, Labbie A. Complications after use of gastric segments for lower urinary tract reconstruction. J Urol. 2012;187(5):1823-1827.
106. Cartwright PC, Snow BW. Bladder autoaugmentation: early clinical experience. J Urol. 1989;142(2 Pt 2):505-508.
107. Garibay JT, Manivel JC, González R. Effect of seromuscular colocystoplasty lined with urothelium and partial detrusorectomy on a new canine model of reduced bladder capacity. J Urol. 1995;154(2 Pt 2):903-906.
108. Swami KS, Feneley RC, Hammonds JC, Abrams P. Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up. Br J Urol. 1998;81(1):68-72.
109. Potter JM, Duffy PG, Gordon EM, Malone PR. Detrusor myotomy: a 5-year review in unstable and non-compliant bladders. BJU Int. 2002;89(9):932-935.
110. MacNeily AE, Afshar K, Coleman GU, Johnson HW. Autoaugmentation by detrusor myotomy: its lack of effectiveness in the management of congenital neuropathic bladder. J Urol. 2003;170(4 Pt 2): 1643-1646.
111. Gurocak S, De Gier RP, Feitz W. Bladder augmentation without integration of intact bowel segments: critical review and future perspectives. J Urol. 2007;177(3):839-844.
112. Buson H, Manivel JC, Dayanç M, Long R, Gonzalez R. Seromuscular colocystoplasty lined with urothelium: experimental study. Urology. 1994;44(5):743-748.
113. Dewan PA, Stefanek W. Autoaugmentation gastrocystoplasty: early clinical results. Br J Urol. 1994;74(4):460-464.
114. Jednak R, Schimke CM, Barroso U Jr, Barthold JS, González R. Further experience with seromuscular colocystoplasty lined with urothelium. J Urol. 2000;164(6):2045-2049.
115. González R, Ludwikowski B, Horst M. Determinants of success and failure of seromuscular colocystoplasty lined with urothelium. J Urol. 2009;182(4 Suppl):1781-1784.
116. Lima SV, Araujo LA, Montoro M, Maciel A, Vilar FO. The use of demucosalized bowel to augment small contracted bladders. Br J Urol. 1998;82(3):436-439.
117. Lima SV, Araújo LA, Vilar FO. Nonsecretory intestinocystoplasty: a 10-year experience. J Urol. 2004;171(6 Pt 2):2636-2639.
118. Chartier Kastler E, Genevois S, Gamé X, et al. Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: a French retrospective multicentre study. BJU Int. 2011;107(3):426-432.
119. Bersch U, Göcking K, Pannek J. The artificial urinary sphincter in patients with spinal cord lesion: description of a modified technique and clinical results. Eur Urol. 2009;55(3):687-693.
120. Murphy S, Rea D, O'Mahony J, et al. A comparison of the functional durability of the AMS 800 artificial urinary sphincter between cases with and without an underlying neurogenic aetiology. Ir J Med Sci. 2003;172(3):136-138.
121. Gonzalez R, Nguyen DH, Koleilat N, Sidi AA. Compatibility of enterocystoplasty and the artificial urinary sphincter. J Urol. 1989;142(2 Pt 2):502-504.
122. Yates DR, Phé V, Rouprêt M, et al. Robot-assisted laparoscopic artificial urinary sphincter insertion in men with neurogenic stress urinary incontinence. BJU Int. 2013;111(7):1175-1179.
123. Pannek J, Bartel P, Gocking K. Clinical usefulness of the transobturator sub-urethral tape in the treatment of stress urinary incontinence in female patients with spinal cord lesion. J Spinal Cord Med. 2012;35(2): 102-106.
124. Daneshmand S, Ginsberg DA, Bennet JK, et al. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol. 2003;169(1):199-202.
125. Perkash I. Transurethral sphincterotomy provides significant relief in autonomic dysreflexia in spinal cord injured male patients: long-term follow-up results. J Urol. 2007;177(3):1026-1029.
126. Moeller BA. Some observations of 31 spinal cord injury patients on whom the Bricker procedure was performed. Paraplegia. 1977;15(3): 230-237.
127. Comarr AE. Renal complications of the ileal conduit and cutaneous vesicostomy among patients with traumatic cord bladders. J Urol. 1972;107(5):762-765.
128. Koziol I, Hackler RH. Cutaneous ureteroileostomy in the spinal cord injured patient: a 15-year experience. J Urol. 1975;114(5):709-711.
129. Kambouris AA, Allaben RD, Carpenter WS, Shumaker EJ. Ileal loop ureteroileostomy in patients with neurogenic bladder. Personal experience with 54 patients. Am J Surg. 1976;131(2):224-227.
130. Chartier-Kastler EJ, Mozer P, Denys P, Bitker MO, Haertig A, Richard F. Neurogenic bladder management and cutaneous non-continent ileal conduit. Spinal Cord. 2002;40(9):443-448.
131. Guillotreau J, Castel-Lacanal E, Roumiguié M, et al. Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction. Neurourol Urodyn. 2011;30(8):1503-1506.
132. Radziszewski K. Outcomes of electrical stimulation of the neurogenic bladder: results of a two-year follow-up study. NeuroRehabilitation. 2013;32(4):867-873.
133. Lin H, Hou C, Zhen X, Xu Z. Clinical study of reconstructed bladder innervation below the level of spinal cord injury to produce urination by Achilles tendon-to-bladder reflex contractions. J Neurosurg Spine. 2009;10(5):452-457.
134. Lin H, Hou C. Transfer of normal S1 nerve root to reinnervate atonic bladder due to conus medullaris injury. Muscle Nerve. 2013;47(2): 241-245.
135. Stenzl A, Strasser H, Klima G, et al. Reconstruction of the lower urinary tract using autologous muscle transfer and cell seeding: current status and future perspectives. World J Urol. 2000;18(1):44-50.
136. Chancellor MB, Rivas DA, Linsenmeyer T, et al. Multicenter trial in North America of UroLume urinary sphincter prosthesis. J Urol. 1994;152(3):924-930.
137. Rivas DA, Chancellor MB, Bagley D. Prospective comparison of external sphincter prosthesis placement and external sphincterotomy in men with spinal cord injury. J Endourol. 1994;8(2):89-93.
138. Mehta SS, Tophill PR. Memokath stents for the treatment of detrusor sphincter dyssynergia (DSD) in men with spinal cord injury: the Princess Royal Spinal Injuries Unit 10-year experience. Spinal Cord. 2006;44(1):1-6.
139. Pokrywczynska M, Adamowicz J, Sharma AK, Drewa T. Human urinary bladder regeneration through tissue engineering-an analysis of 131 clinical cases. Exp Biol Med (Maywood). 2014;239(3): 264-271.
140. Sloff M, Simaioforidis V, de Vries R, Oosterwijk E, Feitz W. Tissue engineering of the bladder-reality or myth? A systematic review. J Urol. 2014;192(4):1035-1042.
141. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367(9518):1241-1246.
142. Joseph DB, Borer JG, De Filippo RE, Hodges SJ, McLorie GA. Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida. J Urol. 2014;191(5):1389-1395.
143. Zhang F, Liao L. Tissue engineered cystoplasty augmentation for treatment of neurogenic bladder using small intestinal submucosa: an exploratory study. J Urol. 2014;192(2):544-550.